| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | DEXCOM INC | Dolan Matthew Vincent | EVP Strategy and Corporate Dev | Apr 15, 2024 | Sale | $137.81 | 1,990 | 274,242 | 42,377 | Apr 16, 2024, 04:16 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | EVP Strategy & Corp Dev | Mar 15, 2024 | Sale | $130.21 | 4,203 | 547,259 | 46,684 | Mar 19, 2024, 04:55 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | EVP Strategy and Corporate | Mar 12, 2024 | Sale | $134.41 | 6,710 | 901,896 | 48,570 | Mar 14, 2024, 05:39 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Sep 01, 2023 | Sale | $102.32 | 56 | 5,730 | 33,569 | Sep 01, 2023, 06:40 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Mar 16, 2023 | Sale | $115.00 | 2,303 | 264,845 | 33,569 | Mar 17, 2023, 04:14 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Mar 10, 2023 | Option Exercise | $111.40 | 6,204 | 691,119 | 46,935 | Mar 14, 2023, 04:46 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Mar 13, 2023 | Sale | $106.27 | 6,229 | 661,956 | 35,872 | Mar 14, 2023, 04:46 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Mar 08, 2023 | Option Exercise | $0.00100 | 21,769 | 22 | 48,305 | Mar 10, 2023, 04:00 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Mar 06, 2023 | Sale | $114.40 | 226 | 25,854 | 26,536 | Mar 06, 2023, 08:04 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | Sep 01, 2022 | Sale | $81.63 | 5 | 408 | 26,536 | Sep 06, 2022, 09:33 AM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Development | Mar 15, 2022 | Sale | $412.41 | 1,016 | 419,009 | 7,804 | Mar 17, 2022, 04:30 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Development | Mar 16, 2022 | Sale | $425.00 | 686 | 291,550 | 7,118 | Mar 17, 2022, 04:30 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Development | Mar 17, 2022 | Sale | $450.00 | 484 | 217,800 | 6,634 | Mar 17, 2022, 04:30 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Development | Mar 08, 2022 | Option Exercise | $0.00100 | 2,889 | 3 | 10,435 | Mar 10, 2022, 07:24 PM | |
| DXCM | DEXCOM INC | Dolan Matthew Vincent | SVP Corporate Development | Mar 09, 2022 | Option Exercise | $406.06 | 1,615 | 655,782 | 10,042 | Mar 10, 2022, 07:24 PM |
Menu